Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Lung|June 22, 2017
Geriatric Assessment and Functional Decline in Older Patients with Lung CancerL Decoster, C Kenis, D Schallier, et al.
ESMO Open|July 17, 2021
Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based studyL van Walle, K Punie, E Van Eycken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2015
Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)V Launay-Vacher, M Aapro, G De Castro, et al.
Breast Cancer Research and Treatment|May 17, 2018
Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancerG Hoste, K Punie, H Wildiers, et al.
Psycho-Oncology|July 15, 2025
From Burden to Empowerment. Patient-Reported Influencing Factors on Participation in Shared Decision Making in Oncology, a Meta-StudyL Mertens, H Wildiers, H Van Veenendaal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2013
Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancersO Brouckaert, A Schoneveld, C Truyers, et al.
British Journal of Cancer|November 11, 2010
Cancer and renal insufficiency results of the BIRMA studyN Janus, V Launay-Vacher, E Byloos, et al.
Sarcoma|May 15, 2007
Ecteinascidin-743: evidence of activity in advanced, pretreated soft tissue and bone sarcoma patientsG Huygh, Paul M J Clement, H Dumez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancerH Wildiers, P Neven, M R Christiaens, et al.
Breast Cancer Research and Treatment|May 13, 2014
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMIA Lintermans, K Van Asten, H Wildiers, et al.
Pageof 9